Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Molecular Endocrinology Laboratory, |
RCV001823852 | SCV002073519 | uncertain significance | Bardet-Biedl syndrome 16 | criteria provided, single submitter | clinical testing | ||
Labcorp Genetics |
RCV001869826 | SCV002182992 | uncertain significance | Senior-Loken syndrome 7; Bardet-Biedl syndrome 16 | 2022-07-12 | criteria provided, single submitter | clinical testing | This sequence change replaces threonine, which is neutral and polar, with lysine, which is basic and polar, at codon 597 of the SDCCAG8 protein (p.Thr597Lys). This variant is present in population databases (rs372641187, gnomAD 0.03%). This variant has not been reported in the literature in individuals affected with SDCCAG8-related conditions. ClinVar contains an entry for this variant (Variation ID: 1339329). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Revvity Omics, |
RCV003136181 | SCV003819234 | uncertain significance | not provided | 2020-03-10 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV003163972 | SCV003864330 | uncertain significance | Inborn genetic diseases | 2023-03-07 | criteria provided, single submitter | clinical testing | The c.1790C>A (p.T597K) alteration is located in exon 15 (coding exon 15) of the SDCCAG8 gene. This alteration results from a C to A substitution at nucleotide position 1790, causing the threonine (T) at amino acid position 597 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |